InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-39.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lu Lucy, Chief Executive Officer. Insider active across 3 companies, notably VERU INC.. Cumulatively, 9 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €65k. Activity tracked since 17 August 2021. The latest transaction was disclosed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000428:0
3,333 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000915:0
11,976 shares@ US$0.835100.0% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-021614:0
Canonical exit: 11 May 2023 (T+90)
50,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-001102:0
30,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-22-128075:0
411,616 shares0Common StockSEC:0001104659-21-151774
411,616 shares0Common StockSEC:0001104659-21-151774:0
9 of 9 declarations
About Lu Lucy
Lucy Lu is the President and CEO of VERU INC. and AVENUE THERAPEUTICS, INC. In these roles, she oversees the operations of both companies and is responsible for overall strategy. Lucy brings extensive experience in the healthcare sector, guiding VERU and AVENUE towards sustainable growth and ongoing innovation.
